Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass.
- 1 March 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Hypertension
- Vol. 17 (3), 288-295
- https://doi.org/10.1161/01.hyp.17.3.288
Abstract
The intrarenal hemodynamic effects of antihypertensive agents vary considerably, and these microcirculatory effects may contribute to long-term structural sequelae in the setting of chronic renal disease. To investigate the consequences of blood pressure reduction with calcium antagonists, 5/6 nephrectomized Munich-Wistar rats underwent baseline determinations of mean arterial pressure, whole kidney function, and single nephron glomerular filtration rate, after which intravenous infusions of verapamil or diltiazem were given in doses that acutely normalized blood pressure; control rats received saline vehicle. During the baseline period, all rats exhibited comparably elevated values for mean arterial pressure and single nephron glomerular filtration rate. During the experimental infusion, control rats exhibited continued single nephron hyperfiltration (84 +/- 8 nl/min) as a result of elevations in both glomerular capillary plasma flow rate (330 +/- 36 nl/min) and glomerular capillary hydraulic pressure (68 +/- 3 mm Hg), whereas the glomerular capillary ultrafiltration coefficient was low [0.050 +/- 0.009 nl/(sec.mm Hg)]. Both verapamil (148 +/- 6 to 103 +/- 3 mm Hg, p less than 0.05) and diltiazem (154 +/- 6 to 102 +/- 2 mm Hg, p less than 0.05) normalized arterial pressure, which did not change in control rats (150 +/- 7 to 142 +/- 8 mm Hg). Single nephron hyperfiltration and hyperperfusion were comparable among groups during the experimental period; compared with baseline values, diltiazem (97 +/- 8 to 71 +/- 7 nl/min, p less than 0.05) but not verapamil (90 +/- 7 to 83 +/- 6 nl/min, p = NS) modestly lowered the single nephron glomerular filtration rate.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 31 references indexed in Scilit:
- Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.Hypertension, 1990
- Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney modelKidney International, 1990
- Long-term enalapril and verapamil in rats with reduced renal massKidney International, 1989
- Short and long term effects of antihypertensive therapy in the diabetic ratKidney International, 1989
- Renal vascular effects of antihypertensive therapy in uninephrectomized SHRKidney International, 1989
- Progression of renal insufficiency: Role of blood pressureKidney International, 1989
- Glomerular hypertension and injury in desoxycorticosterone–salt rats on antihypertensive therapyKidney International, 1987
- Verapamil protects against progression of experimental chronic renal failureKidney International, 1987
- Reversal of renal cortical actions of angiotensin II by verapamil and manganeseKidney International, 1979